Cargando…
Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states
The anti-diabetic drug, metformin, exerts its action through AMP-activated protein kinase (AMPK), and Sirtuin (Sirt1) signaling. Insulin-like growth factor (IGF)-binding protein 2 (IGFBP-2) prevents IGF-1 binding to its receptors, thereby contributing to modulate insulin sensitivity. In this study,...
Autores principales: | Kang, Hye Suk, Cho, Ho-Chan, Lee, Jae-Ho, Oh, Goo Taeg, Koo, Seung-Hoi, Park, Byung-Hyun, Lee, In-Kyu, Choi, Hueng-Sik, Song, Dae-Kyu, Im, Seung-Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806307/ https://www.ncbi.nlm.nih.gov/pubmed/27009398 http://dx.doi.org/10.1038/srep23665 |
Ejemplares similares
-
Regulation of IGFBP-2 expression during fasting
por: Kang, Hye Suk, et al.
Publicado: (2015) -
Regulation of IGFBP-1 in Metabolic Diseases
por: Bae, Jae-Hoon, et al.
Publicado: (2013) -
PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression
por: de Vogel-van den Bosch, Heleen M, et al.
Publicado: (2008) -
Orphan Nuclear Receptor Errγ Induces C-Reactive Protein Gene Expression through Induction of ER-Bound Bzip Transmembrane Transcription Factor CREBH
por: Misra, Jagannath, et al.
Publicado: (2014) -
Identification of Pre-Diabetic Biomarkers in the Progression of Diabetes Mellitus
por: Lee, Jae-Ho, et al.
Publicado: (2021)